We could demonstrate that mast cells from AD patients showed a significantly higher baseline mRNA expression of H2R (12,5-fold) and H4R (5,0-fold) when compared to mast cells from HVs (Fig. 6A and B). The gene discussed is HRH2; the disease is Alzheimer disease.